{"id":"W3093155650","doi":"10.1016/s2665-9913(20)30237-x","title":"Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network; Western University; Mount Sinai Hospital","funders":"National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Michigan; National Institute of Allergy and Infectious Diseases; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Placebo; Open label; Clinical endpoint; Double blind; Clinical trial; Internal medicine; Scleroderma (fungus); Surgery; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005290383,0.0002062942,0.001937746,0.00008934861,0.0000549756,0.00001757761,0.0003442248,0.0002060549,0.00003061925],"category_scores_gemma":[0.0005350747,0.0001286713,0.00009291916,0.0003087815,0.0002333171,0.00005425101,0.0001653124,0.0002504706,0.000008051227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002407289,"about_ca_system_score_gemma":0.0001166319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003287701,"about_ca_topic_score_gemma":0.000006039591,"domain_scores_codex":[0.9976492,0.0003463806,0.001134247,0.0003681617,0.0002186446,0.0002833993],"domain_scores_gemma":[0.9978753,0.0008204211,0.0005412588,0.0005135704,0.00008902426,0.0001604771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9556102,0.00141489,0.002713527,0.0005071521,0.0002925852,0.00003439057,0.002244246,0.00001164159,0.03450172,0.0002212325,0.0004788212,0.001969624],"study_design_scores_gemma":[0.9903762,0.001414245,0.001202415,0.003783388,0.0003272609,0.0004731458,0.0003360101,0.0006818431,0.001235829,0.00001010405,0.00002185417,0.0001376583],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877775,0.007129354,0.00003622404,0.001436964,0.0001875457,0.00323034,0.00003612976,0.00003341736,0.0001325241],"genre_scores_gemma":[0.994154,0.005497361,0.00004056524,0.0001392054,0.00005003414,0.00005614069,0.00002281005,0.00002509097,0.00001478774],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03476608,"threshold_uncertainty_score":0.5247064,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1044349668884315,"score_gpt":0.3364564423970087,"score_spread":0.2320214755085772,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}